Literature DB >> 19597170

Does diabetes double the risk of depression?

Patrick J O'Connor1, A Lauren Crain, William A Rush, Ann M Hanson, Lucy Rose Fischer, John C Kluznik.   

Abstract

PURPOSE: In this study, we compared the rate of depression diagnoses in adults with and without diabetes mellitus, while carefully controlling for number of primary care visits.
METHODS: We matched adults with incident diabetes (n = 2,932) or prevalent diabetes (n = 14,144) to nondiabetic control patients based on (1) age and sex, or (2) age, sex, and number of outpatient primary care visits. Logistic regression analysis was used to assess the association between various predictors and a diagnosis of depression in each diabetes cohort relative to matched nondiabetic control patients.
RESULTS: With matching for age and sex alone, patients with prevalent diabetes having few primary care visits were significantly more likely to have a new depression diagnosis than matched control patients (odds ratio [OR] = 1.46, 95% confidence interval [CI], 1.19-1.80), but this relationship diminished when patients made more than 10 primary care visits (OR = 0.95, 95% CI, 0.77-1.17). With additional matching for number of primary care visits, patients with prevalent diabetes mellitus with few primary care visits were more likely to have a new diagnosis of depression than those in control group (OR = 1.32, 95% CI, 1.07-1.63), but this relationship diminished and reversed when patients made more than 4 primary care visits (OR = 0.99, 95% CI, 0.80-1.23). Similar results were observed in the subset of patients with incident diabetes and their matched control patients.
CONCLUSIONS: Patients with diabetes have little or no increase in the risk of a new diagnosis of depression relative to nondiabetic patients when analyses carefully control for the number of outpatient visits. Studies showing such an association may have inadequately adjusted for comorbidity or for exposure to the medical care system.

Entities:  

Mesh:

Year:  2009        PMID: 19597170      PMCID: PMC2713167          DOI: 10.1370/afm.964

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  25 in total

1.  Depression and poor glycemic control: a meta-analytic review of the literature.

Authors:  P J Lustman; R J Anderson; K E Freedland; M de Groot; R M Carney; R E Clouse
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

2.  Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care.

Authors:  Enid M Hunkeler; Wayne Katon; Lingqi Tang; John W Williams; Kurt Kroenke; Elizabeth H B Lin; Linda H Harpole; Patricia Arean; Stuart Levine; Lydia M Grypma; William A Hargreaves; Jürgen Unützer
Journal:  BMJ       Date:  2006-01-20

3.  Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.

Authors:  Wayne Katon; Jürgen Unützer; Ming-Yu Fan; John W Williams; Michael Schoenbaum; Elizabeth H B Lin; Enid M Hunkeler
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

4.  The role of competing demands in the treatment provided primary care patients with major depression.

Authors:  K Rost; P Nutting; J Smith; J C Coyne; L Cooper-Patrick; L Rubenstein
Journal:  Arch Fam Med       Date:  2000-02

5.  Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression.

Authors:  Leif I Solberg; Karen I Engebretson; Joann M Sperl-Hillen; Mary C Hroscikoski; Patrick J O'Connor
Journal:  Am J Med Qual       Date:  2006 Jul-Aug       Impact factor: 1.852

6.  Relations of diabetes intrusiveness and personal control to symptoms of depression among adults with diabetes.

Authors:  F Talbot; A Nouwen; J Gingras; A Bélanger; J Audet
Journal:  Health Psychol       Date:  1999-09       Impact factor: 4.267

7.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

8.  Examining a bidirectional association between depressive symptoms and diabetes.

Authors:  Sherita Hill Golden; Mariana Lazo; Mercedes Carnethon; Alain G Bertoni; Pamela J Schreiner; Ana V Diez Roux; Hochang Benjamin Lee; Constantine Lyketsos
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

9.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

10.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

View more
  29 in total

1.  Variations in the probability of depression screening at community-based physician practice visits.

Authors:  Donald L Harrison; Michael J Miller; Michael R Schmitt; Bryan K Touchet
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Incidence and risk of depression associated with diabetes in adults: evidence from longitudinal studies.

Authors:  Syed Shahzad Hasan; Abdullah A Mamun; Alexandra M Clavarino; Therese Kairuz
Journal:  Community Ment Health J       Date:  2014-06-21

Review 3.  Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus.

Authors:  Boon How Chew; Rimke C Vos; Maria-Inti Metzendorf; Rob Jpm Scholten; Guy Ehm Rutten
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

4.  Depressive states among adults with diabetes: Findings from the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Juan Rafael Albertorio-Diaz; Mark S Eberhardt; Maria Oquendo; Marco Mesa-Frias; Yulei He; Bruce Jonas; Kai Kang
Journal:  Diabetes Res Clin Pract       Date:  2017-02-27       Impact factor: 5.602

5.  Depression, self-esteem, diabetes care and self-care behaviors among middle-aged and older Mexicans.

Authors:  Maricruz Rivera-Hernandez
Journal:  Diabetes Res Clin Pract       Date:  2014-04-28       Impact factor: 5.602

6.  Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study.

Authors:  Beth Waitzfelder; Robert B Gerzoff; Andrew J Karter; Stephen Crystal; Mathew J Bair; Susan L Ettner; Arleen F Brown; Usha Subramanian; Shou-En Lu; David Marrero; William H Herman; Joseph V Selby; R Adams Dudley
Journal:  Prim Care Diabetes       Date:  2010-09-15       Impact factor: 2.459

7.  Mindfulness-Based Stress Reduction and Diabetes.

Authors:  Robin R Whitebird; Mary Jo Kreitzer; Patrick J O'Connor
Journal:  Diabetes Spectr       Date:  2009-09-21

8.  Relationships between obesity management and depression management in a university-based family medicine center.

Authors:  Emily R Barnes; Laurie Theeke; Elizabeth Minchau; Jennifer Mallow; Noelle Lucke-Wold; Jason Wampler
Journal:  J Am Assoc Nurse Pract       Date:  2014-09-13       Impact factor: 1.165

9.  Effect of comorbid depression on outcomes in diabetes and its relationship to quality of care and patient adherence: a statewide primary care ambulatory research and resources consortium study.

Authors:  David Katerndahl; Walter L Calmbach; Johanna Becho
Journal:  Prim Care Companion CNS Disord       Date:  2012-05-03

10.  Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses.

Authors:  Lawrence Fisher; Joseph T Mullan; Patricia Arean; Russell E Glasgow; Danielle Hessler; Umesh Masharani
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.